Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeanne Galaine

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Cancer Research|July 18, 2022
Antitumor CAR T-cell Screening Platform: Many Are Called, but Few Are ChosenOlivier Adotévi, Jeanne Galaine
Bulletin Du Cancer|January 7, 2017
Jeanne Galaine, Yann Godet, Olivier Adotévi
Vaccines|September 10, 2015
Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer VaccineJeanne Galaine, Christophe Borg, Yann Godet, et al.
Bulletin Du Cancer|January 29, 2019
Marie-Thérèse Rubio, Jeanne Galaine, Christophe Borg, et al.
Cancer Gene Therapy|April 12, 2024
CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapyValentine De Castro, Jeanne Galaine, Romain Loyon, et al.
Cellular Immunology|March 7, 2021
An unmet need: Harmonization of IL-7 and IL-15 combination for the ex vivo generation of minimally differentiated T cellsChrystel Marton, Patricia Mercier-Letondal, Jeanne Galaine, et al.
Journal of Translational Medicine|January 7, 2021
Validation of a method evaluating T cell metabolic potential in compliance with ICH Q2 (R1)Patricia Mercier-Letondal, Chrystel Marton, Yann Godet, et al.
Human Vaccines & Immunotherapeutics|January 30, 2013
Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccineOlivier Adotévi, Magalie Dosset, Jeanne Galaine, et al.
The British Journal of Dermatology|April 6, 2023
Production of functional plasmacytoid dendritic cells - targeted chimeric antigen receptor T cells from patients with immune-mediated inflammatory diseasesBlandine Caël, Elodie Bôle-Richard, Jeanne Galaine, et al.
Cancer Gene Therapy|October 14, 2021
Homeostatic cytokines tune naivety and stemness of cord blood-derived transgenic T cellsChrystel Marton, Patricia Mercier-Letondal, Romain Loyon, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Cancer Research|July 18, 2022
Antitumor CAR T-cell Screening Platform: Many Are Called, but Few Are ChosenOlivier Adotévi, Jeanne Galaine
Bulletin Du Cancer|January 7, 2017
Jeanne Galaine, Yann Godet, Olivier Adotévi
Vaccines|September 10, 2015
Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer VaccineJeanne Galaine, Christophe Borg, Yann Godet, et al.
Bulletin Du Cancer|January 29, 2019
Marie-Thérèse Rubio, Jeanne Galaine, Christophe Borg, et al.
Cancer Gene Therapy|April 12, 2024
CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapyValentine De Castro, Jeanne Galaine, Romain Loyon, et al.
Cellular Immunology|March 7, 2021
An unmet need: Harmonization of IL-7 and IL-15 combination for the ex vivo generation of minimally differentiated T cellsChrystel Marton, Patricia Mercier-Letondal, Jeanne Galaine, et al.
Journal of Translational Medicine|January 7, 2021
Validation of a method evaluating T cell metabolic potential in compliance with ICH Q2 (R1)Patricia Mercier-Letondal, Chrystel Marton, Yann Godet, et al.
Human Vaccines & Immunotherapeutics|January 30, 2013
Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccineOlivier Adotévi, Magalie Dosset, Jeanne Galaine, et al.
The British Journal of Dermatology|April 6, 2023
Production of functional plasmacytoid dendritic cells - targeted chimeric antigen receptor T cells from patients with immune-mediated inflammatory diseasesBlandine Caël, Elodie Bôle-Richard, Jeanne Galaine, et al.
Cancer Gene Therapy|October 14, 2021
Homeostatic cytokines tune naivety and stemness of cord blood-derived transgenic T cellsChrystel Marton, Patricia Mercier-Letondal, Romain Loyon, et al.
Pageof 3